Blockade of the PPARα metabolic checkpoint with TPST-1120 suppresses tumor growth and stimulates anti-tumor immunity

被引：1
|
作者：
Whiting, Chan C. [1 ]
Stock, Nick [2 ]
Messmer, Davorka [2 ]
Olafson, Traci [2 ]
Metzger, Derek [1 ]
Enstrom, Amanda [1 ]
McDevitt, Jennifer [1 ]
Spaner, David [3 ]
Prasit, Peppi [2 ]
Panigrahy, Dipak [4 ]
Laport, Ginna [1 ]
机构：
[1] Tempest Therapeut, San Francisco, CA USA
[2] Incept Sci, San Diego, CA USA
[3] Sunnybrook Res Inst, Toronto, ON, Canada
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-3606
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3606
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tissue site of tumor growth dictates anti-tumor immunity and response to checkpoint blockade
    Horton, Brendan
    Spranger, Stefani
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
    Sheng, Wanqiang
    LaFleur, Martin W.
    Nguyen, Thao H.
    Chen, Sujun
    Chakravarthy, Ankur
    Conway, Jake Ryan
    Li, Ying
    Chen, Hao
    Yang, Henry
    Hsu, Pang-Hung
    Van Allen, Eliezer M.
    Freeman, Gordon J.
    De Carvalho, Daniel D.
    He, Housheng Hansen
    Sharpe, Arlene H.
    Shi, Yang
    CELL, 2018, 174 (03) : 549 - +
  • [3] Dual antagonism of prostaglandin receptors EP2 and EP4 by TPST-1495 suppresses tumor growth and stimulates anti-tumor immunity
    Whiting, Chan
    Fischer, Kim
    Laffitte, Bryan
    Rahbaek, Lisa
    Stock, Nick
    Messmer, Davorka
    Chen, Austin
    Olafson, Traci
    Nguyen, Natalie
    Enstrom, Amanda
    Metzger, Derek
    Francica, Brian
    Wang, Dingzhi
    Dubois, Raymond
    Laport, Ginna
    Prasit, Peppi
    Dubensky, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade
    Srour, Nivine
    Villarreal, Oscar D.
    Hardikar, Swanand
    Yu, Zhenbao
    Preston, Samuel
    Miller, Wilson H., Jr.
    Szewczyk, Magdelena M.
    Barsyte-Lovejoy, Dalia
    Xu, Han
    Chen, Taiping
    Del Rincon, Sonia, V
    Richard, Stephane
    CELL REPORTS, 2022, 38 (13):
  • [5] Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity
    Scharping, Nicole E.
    Delgoffe, Greg M.
    VACCINES, 2016, 4 (04)
  • [6] Marvelon suppresses MC38 tumor growth and promotes anti-tumor immunity
    Kong, Fandi
    Chen, Yongyan
    Liu, Dantong
    Gao, Hongying
    Yi, Qiaoru
    Zhang, Mengjuan
    Li, Dan
    MOLECULAR IMMUNOLOGY, 2025, 182 : 20 - 29
  • [7] Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade
    Rwandamuriye, Francois Xavier
    Wang, Tao
    Zhang, Hanfu
    Elaskalani, Omar
    Kuster, Jorren
    Ye, Xueting
    Vitali, Breana
    Schreurs, Juliet
    Morales, M. Lizeth Orozco
    Norret, Marck
    Evans, Cameron W.
    Zemek, Rachael M.
    Iyer, K. Swaminathan
    Lesterhuis, W. Joost
    Wylie, Ben
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [8] Metabolic reprograming of anti-tumor immunity
    Sukumar, Madhusudhanan
    Kishton, Rigel J.
    Restifo, Nicholas P.
    CURRENT OPINION IN IMMUNOLOGY, 2017, 46 : 14 - 22
  • [9] MerTK Blockade Fuels Anti-tumor Immunity
    Blander, J. Magarian
    IMMUNITY, 2020, 52 (02) : 212 - 214
  • [10] Tumor cell-derived lactic acid inhibit anti-tumor immunity in the immune checkpoint blockade resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Sun, Ruoxuan
    Lim, Seung-Oe
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
12345